Editor's Choice
Experity Appoints Brian Berning as Chief Financial Officer09 Jan 2023
What You Should Know: – Experity, the national leader in on-demand healthcare solutions, announced the appointment of Brian Berning as the... Continue Reading
|
The Patient Journey Tech Stack: 10 Pharma Predictions for 202309 Jan 2023
The complexity of demands on Market Access teams has increased in recent years, between introducing innovative therapies targeting smaller populations... Continue Reading
|
Withings Unveils Mini At-Home Urine Analysis Platform for Clinical Trials & RPM09 Jan 2023
What You Should Know: – During a press preview event at CES last night, Withings unveiled, U-Scan, a miniaturized urine... Continue Reading
|
First Stop Health Promotes Teira Gunlock to CEO09 Jan 2023
What You Should Know: – First Stop Health (FSH), a leading virtual care company for primary, urgent and mental healthcare needs, today announced the promotion... Continue Reading
|
Procaps to Present at 2023 Annual J.P. Morgan Healthcare Conference02 Jan 2023
Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced that... Continue Reading
|
Why the Future of Lateral Flow Testing is Digital02 Jan 2023
Lateral flow immunoassay tests (or LFTs, for short) have been in use for decades, becoming an indispensable tool within diagnostics’... Continue Reading
|
CEL-SCI Reports Fiscal 2022 Financial Results and Clinical & Corporate Developments02 Jan 2023
CEL-SCI Corporation (NYSE American: CVM) reported financial results for the fiscal year ended September 30, 2022, as well as key clinical and... Continue Reading
|
Heal Plans Layoffs Ahead of the Potential Sale and More Digital Health Briefs02 Jan 2023
Heal, a home-based primary care and telehealth company, is planning layoffs ahead of a potential sale. According to WARN notices,... Continue Reading
|
Digital Health Leaders Predict More Stabilized Funding in 202302 Jan 2023
Leaders in the digital health space told MobiHealthNews their predictions about investors’ priorities in the coming year and what companies... Continue Reading
|
Click Therapeutics Shares 2022 Accomplishments and Development Progress in its Prescription Digital Therapeutics Programs26 Dec 2022
NEW YORK–(BUSINESS WIRE)–Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today shared multiple accomplishments and advances... Continue Reading
|